Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2026 Earnings Call Transcript May 5, 2026
Jazz Pharmaceuticals plc beats earnings expectations. Reported EPS is $6.34, expectations were $4.67.
Operator: Good day, and thank you for standing by. Welcome to the Jazz Pharmaceuticals plc 2026 first quarter earnings conference call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. To ask a question during the session,...
